528 related articles for article (PubMed ID: 35883004)
1. Cancer-associated fibroblasts in the single-cell era.
Lavie D; Ben-Shmuel A; Erez N; Scherz-Shouval R
Nat Cancer; 2022 Jul; 3(7):793-807. PubMed ID: 35883004
[TBL] [Abstract][Full Text] [Related]
2. Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma progression and therapeutic resistance.
Ravichandra A; Bhattacharjee S; Affò S
Adv Cancer Res; 2022; 156():201-226. PubMed ID: 35961700
[TBL] [Abstract][Full Text] [Related]
3. From gatekeepers to providers: regulation of immune functions by cancer-associated fibroblasts.
Arpinati L; Scherz-Shouval R
Trends Cancer; 2023 May; 9(5):421-443. PubMed ID: 36870916
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity and plasticity of cancer-associated fibroblasts in the pancreatic tumor microenvironment.
Boyd LNC; Andini KD; Peters GJ; Kazemier G; Giovannetti E
Semin Cancer Biol; 2022 Jul; 82():184-196. PubMed ID: 33737108
[TBL] [Abstract][Full Text] [Related]
5. The Origin, Differentiation, and Functions of Cancer-Associated Fibroblasts in Gastrointestinal Cancer.
Huang J; Tsang WY; Li ZH; Guan XY
Cell Mol Gastroenterol Hepatol; 2023; 16(4):503-511. PubMed ID: 37451403
[TBL] [Abstract][Full Text] [Related]
6. Fibroblasts in Orchestrating Colorectal Tumorigenesis and Progression.
Abudukelimu S; de Miranda NFCC; Hawinkels LJAC
Cell Mol Gastroenterol Hepatol; 2024; 17(5):821-826. PubMed ID: 38307492
[TBL] [Abstract][Full Text] [Related]
7. Multiomic analysis reveals conservation of cancer-associated fibroblast phenotypes across species and tissue of origin.
Foster DS; Januszyk M; Delitto D; Yost KE; Griffin M; Guo J; Guardino N; Delitto AE; Chinta M; Burcham AR; Nguyen AT; Bauer-Rowe KE; Titan AL; Salhotra A; Jones RE; da Silva O; Lindsay HG; Berry CE; Chen K; Henn D; Mascharak S; Talbott HE; Kim A; Nosrati F; Sivaraj D; Ransom RC; Matthews M; Khan A; Wagh D; Coller J; Gurtner GC; Wan DC; Wapnir IL; Chang HY; Norton JA; Longaker MT
Cancer Cell; 2022 Nov; 40(11):1392-1406.e7. PubMed ID: 36270275
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of cancer-associated fibroblasts: Opportunities for precision medicine.
Kanzaki R; Pietras K
Cancer Sci; 2020 Aug; 111(8):2708-2717. PubMed ID: 32573845
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated fibroblasts subtypes and role in invasion and metastasis of gastric cancer.
Zhang M; Guan WB; Li JL; Li LX; Wang KZ; Wang RF; Wang LF
Neoplasma; 2022 Dec; 69(6):1277-1288. PubMed ID: 36129833
[TBL] [Abstract][Full Text] [Related]
10. Cancer-associated fibroblasts: from basic science to anticancer therapy.
Yang D; Liu J; Qian H; Zhuang Q
Exp Mol Med; 2023 Jul; 55(7):1322-1332. PubMed ID: 37394578
[TBL] [Abstract][Full Text] [Related]
11. Transcription factors in fibroblast plasticity and CAF heterogeneity.
Melchionna R; Trono P; Di Carlo A; Di Modugno F; Nisticò P
J Exp Clin Cancer Res; 2023 Dec; 42(1):347. PubMed ID: 38124183
[TBL] [Abstract][Full Text] [Related]
12. Targeting CAFs to overcome anticancer therapeutic resistance.
Saw PE; Chen J; Song E
Trends Cancer; 2022 Jul; 8(7):527-555. PubMed ID: 35331673
[TBL] [Abstract][Full Text] [Related]
13. Cancer-Associated Fibroblasts in Inflammation and Antitumor Immunity.
Kennel KB; Bozlar M; De Valk AF; Greten FR
Clin Cancer Res; 2023 Mar; 29(6):1009-1016. PubMed ID: 36399325
[TBL] [Abstract][Full Text] [Related]
14. [Cancer-Associated Fibroblasts: Heterogeneity and Bimodality in Oncogenesis].
Lunina NA; Safina DR; Kostrov SV
Mol Biol (Mosk); 2023; 57(5):739-770. PubMed ID: 37752641
[TBL] [Abstract][Full Text] [Related]
15. Targeting cancer-associated fibroblasts: Challenges, opportunities and future directions.
Jenkins BH; Buckingham JF; Hanley CJ; Thomas GJ
Pharmacol Ther; 2022 Dec; 240():108231. PubMed ID: 35718294
[TBL] [Abstract][Full Text] [Related]
16. What is new in cancer-associated fibroblast biomarkers?
Zhao Z; Li T; Yuan Y; Zhu Y
Cell Commun Signal; 2023 May; 21(1):96. PubMed ID: 37143134
[TBL] [Abstract][Full Text] [Related]
17. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
[TBL] [Abstract][Full Text] [Related]
18. Single-cell RNA sequencing to explore cancer-associated fibroblasts heterogeneity: "Single" vision for "heterogeneous" environment.
Zhang X; Zhu R; Yu D; Wang J; Yan Y; Xu K
Cell Prolif; 2024 May; 57(5):e13592. PubMed ID: 38158643
[TBL] [Abstract][Full Text] [Related]
19. Turning foes to friends: targeting cancer-associated fibroblasts.
Chen X; Song E
Nat Rev Drug Discov; 2019 Feb; 18(2):99-115. PubMed ID: 30470818
[TBL] [Abstract][Full Text] [Related]
20. Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment.
Bu L; Baba H; Yoshida N; Miyake K; Yasuda T; Uchihara T; Tan P; Ishimoto T
Oncogene; 2019 Jun; 38(25):4887-4901. PubMed ID: 30816343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
